Sinusitis and Facial Pain Disorders Anti-Depression Trial

PHASE4TerminatedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

August 31, 2010

Study Completion Date

December 31, 2012

Conditions
Chronic SinusitisFacial Pain DisorderDepression
Interventions
DRUG

escitalopram

10mg - 30mg daily titrated as tolerated over 12 weeks

DRUG

placebo

inactive comparator; titrated as per protocol over 12 weeks

Trial Locations (1)

98195

University of Washington Medical Center, Seattle

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

Forest Laboratories

INDUSTRY

lead

University of Washington

OTHER

NCT00754793 - Sinusitis and Facial Pain Disorders Anti-Depression Trial | Biotech Hunter | Biotech Hunter